Professional Documents
Culture Documents
Sexually_Treated_Infections-Dr_Monze
Sexually_Treated_Infections-Dr_Monze
• Sexually transmitted diseases (STD's) are among the most common infectious
diseases in Zambia today.
• STD's affect men and women of all backgrounds and economic levels.
• They are most prevalent among teenagers and young adults.
• The incidence of STD's is rising because sexually active people are increasingly
having multiple sex partners:
– young people have become sexually active earlier yet are marrying later
– divorce is more common.
• They are not easily identified:
– Usually STD's cause no symptoms, especially in women.
– If symptoms develop, they may be confused with those of other diseases.
– Even when symptomless, a person can pass the disease on to a sex partner (ex.
genital herpes, HIV).
– Strong social stigma which prevents open discussion
Clinical Manifestations
Gonococcal urethritis
Non-gonococcal urethritis
Microbiologic Diagnosis
• Neisseria gonorrhoeae
• Microscopic examination of urethral exudates. Gram stain for leukocytes and
Gram-negative intracellular diplococci. Good sensitivity and specificity in males
• Culturing of the organism - urethral exudate planted directly onto a split plate
containing modified Thayer-Martin and chocolate agar.
• Rapid methods such as antigen or nucleic acid detection. Fluorescent-antibody
analysis using monoclonal antibodies may also be used to confirm the identity of
cultures. Culture confirmation can also be performed using DNA probes that detect
specific sequences of the rRNA of N gonorrhoeae.
• Chlamydia trachomatis
• Growing the organism in tissue culture It is an intracellular parasite thus infected
urethral cells must be collected on the swab samples which are then used to inoculate cell
culture lines. After 48 to 72 hours, the monolayer is fixed and, after staining, is examined
for chlamydial inclusion bodies.
• Direct bacterial antigen detection techniques including either direct visualization
of the organism using fluorescein-conjugated antibodies or enzyme-like immunosorbent
assay (ELISA) methods which detect solubilized chlamydial LPS.
• Nucleic acid detection systems using PCR are now commercially available.
Clinical Presentation
• Endometritis and pelvic inflammatory disease usually result from ascending
vaginal or cervical infections.
• Vaginal infections seldom have systemic manifestations; they present as an
abnormal vaginal discharge that may have an unusual odor.
• Pruritus may also be present.
• Mucosal ulceration of the vagina results in local discomfort and pain on
intercourse.
• Abdominal discomfort is rare in vaginitis, and is more suggestive of cystitis or
pelvic inflammatory disease.
• The consistency of the discharge often reflects the nature of the disease.
– Bacterial or non-specific vaginosis - a thin watery discharge that sticks to the
anterior and lateral vaginal walls. The vaginal walls appear normal.
– Candidiasis - vaginal walls are erythematous
– Trichomoniasis - they have a strawberry appearance and the vaginal discharge is
green and frothy.
– A yellow, purulent discharge suggests cervicitis or other forms of vaginitis.
Pathogenesis
Chancroid
Lymphogranuloma venereum
• Chlamydia trachomatis serovars L1, L2, and L3 are the agents of
lymphogranuloma venereum. These strains of C trachomatis differ from ocular and
nongonococcal causing strains in being more invasive in a mouse model and more
resistant to trypsin treatment.
• Usually begins as a painless papule that frequently goes unnoticed.
• The second stage of the disease involves enlargement of regional lymph nodes
• The third stage manifests as rectal strictures and fibrosis.
Granuloma inguinale
• Caused by Calmatobacterium granulomatis, which is usually demonstrated as
intracellular Donovan bodies visualized by Warthin-Starry silver stain or Giemsa stain of
histologic sections.
• Begins as a painless papule that ultimately develops into a painless, raised, beefy-
red lesion.
Granuloma inguinale
• Chlamydia trachomatis serovars L1, L2 and L3 and Calmatobacterium
granulomatis both remain localized at the site of ulceration but sometimes may show
contiguous spread.
Herpes simplex
• Caused by herpes simplex virus type I
• Lesions begin as small papules that develop into extremely painful vesicles or
ulcers.
• Recurrent appearance of vesicles
Microbiologic Diagnosis
• Culture is critical to confirming the diagnosis:
– Because the clinical symptoms of the genital ulcer diseases overlap
– And because two or more pathogens may be present simultaneously
• Fluid from the lesion (ulcer or bubo exudate) is collected and examined as
follows:
– Chancroid - The organism is fastidious but can be grown in 48 hours by culturing
on Mueller-Hinton or GC medium enriched with IsoVitaleX, fetal bovine serum, and
vancomycin. Even under optimal culture conditions, the isolation rates are between 50
and 80 percent.
– Treponema pallidum - dark-field examination of ulcer material for spirochetes
and by serologic detection of an antibody response.
– Herpes simplex - vesicular fluid for a viral culture or antigen detection.
– Lymphogranuloma venereum - culturing C trachomatis and examination for
inclusion bodies in the inoculated cell line. Antigen detection methods using fluorescein-
conjugated antibody have also proved useful.
– Calmatobacterium granulomatis is usually detected by staining histologic
sections with Warthin-Starry silver stain and observing Donovan bodies within the host
cells.
Genital Warts
• Condyloma acuminatum, anogenital warts and exophytic warts – large moist
excrescences of soft papillomas found on the external genitalia, perineum, vaginal
introitus, penis or anus caused by human papilloma virus types 6 and 11
• Condyloma planum (flat wart) is the presentation on the cervix
• Cervical carcinoma may develop 20-50 yrs after infection
Genital Warts
• Clinical diagnosis is obvious
• Histology is required whenever malignancy is a possibility
Ectoparasites
• Phthirus pubis - Pubic louse infestation
• Sarcoptes scabei - Scabies
STD Prevention
• The prevention and control of STDs is based on the following five major
concepts:
– education and counseling of persons at risk on ways to adopt safer sexual
behavior;
– identification of asymptomatically infected persons and of symptomatic persons
unlikely to seek diagnostic and treatment services;
– effective diagnosis and treatment of infected persons;
– evaluation, treatment, and counseling of sex partners of persons who are infected
with an STD; and
– preexposure vaccination of persons at risk for vaccine-preventable STDs (Hep A
and B)